AC Immune, a Swiss clinical stage biopharmaceutical company pioneering in precision medicine for neurodegenerative diseases listed on the Nasdaq completed an underwritten offering of 14.3 million of its common shares at a price of USD 3.50 per
Tags :Homburger
The canton of Basel-City has embraced the future of finance by issuing CHF 105 million in digital bonds. At the forefront of this pioneering initiative, Basler Kantonalbank (BKB) took the helm as lead manager, orchestrating a
Wöhrle Group, headquartered in Wildberg, Germany, has announced that it had acquired the Swiss Oskar Rüegg Holding and its subsidiaries (Switzerland / Bulgaria / Mexico). Both companies specialize in the manufacture of sophisticated stamped parts
Müller Martini and Hunkeler, both renowned companies with innovative solutions for post-print paper processing, announced the combination of the two businesses. Müller Martini Holding has acquired all shares in Hunkeler Holding from the
In a groundbreaking move, Givaudan Finance Europe B.V. has launched EUR 500 million 4.125% Guaranteed Bonds due 2033. The bonds, fortified by the guarantee of the Swiss group’s parent company, Givaudan, mark a significant milestone for
Homburger played a key advisory role for JPW Industries Holding Corporation in a strategic move involving the refinancing of its 9.000% senior secured notes due 2024. The process included the establishment of a new term loan and
Kandou Holding (Kandou) has completed the initial phase of its USD 100 million Series E equity financing with legal counsel provided by Homburger. This round brings Kandou’s total equity investment to USD 280 million, further solidifying
Homburger provided legal counsel to Commerzbank Aktiengesellschaft for a syndicated corporate financing deal involving Montana Aerospace. This company is a well-known manufacturer of aerospace system components and complex assemblies, operating globally with development and production
Nanogence closed its Series A financing round, securing financing from a consortium of investors. The consortium was led by CirCap, an investment platform providing strategic private capital to innovative companies in climate-tech, healthcare and education,
Roche Holdings successfully completed its issuance of USD 5.5 billion in aggregate principal amount of senior notes, consisting of USD 1.1 bn 5.265% Notes due 2026, USD 1.25 bn 5.338% Notes due 2028, USD 1.25 bn 5.489% Notes due 2030, USD 1.6 bn 5.593% Notes due 2033, and